Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era

Nachiketh Soodana Prakash, Diana M. Lopategui, Christopher Gomez

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Bladder compliance is a measure of distensibility. Maladies such as myelodysplasia, myelomeningocele, spinal cord injury, multiple sclerosis and obstructive uropathy are known to decrease bladder compliance. Decrease in bladder compliance is a characteristic of neurogenic bladders. The pathophysiology of bladder compliance is complex but ultimately leads to high pressure during filling and storage phases. These high pressures lead to renal impairment, incontinence, and recurrent urinary tract infections. This review presents management of poorly compliant bladders with onabotulinumtoxinA.

Original languageEnglish (US)
Article number64
JournalCurrent Urology Reports
Issue number8
StatePublished - Aug 1 2017


  • Bladder compliance
  • Botox
  • Hypocompliant bladder
  • OnabotulinumtoxinA
  • SCI

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era'. Together they form a unique fingerprint.

Cite this